Search research articles
Contact Us
Filters
Showing results (151-160 of 344) with videos related to
Page
of 35
Sort By:
BMJ Open
|
July 16, 2020
Protocol for a single-arm confirmatory trial of adjuvant chemoradiation for patients with high-risk rectal submucosal invasive cancer after local resection: Japan Clinical Oncology Group Study JCOG1612 (RESCUE study)
Tomohiro Kadota, Hiroaki Ikematsu, Takeshi Sasaki, et al.
Japanese Journal of Clinical Oncology
|
September 11, 2015
A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study)
Kozo Kataoka, Masanori Tokunaga, Junki Mizusawa, et al.
Japanese Journal of Clinical Oncology
|
April 17, 2018
Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study
Yoichi Naito, Hideaki Takahashi, Kohei Shitara, et al.
BMC Cancer
|
December 29, 2019
Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
Daisuke Kotani, Yasutoshi Kuboki, Satoshi Horasawa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 23, 2016
A multicenter phase II study of TAS-102 monotherapy in patients with pre-treated advanced gastric cancer (EPOC1201)
Hideaki Bando, Toshihiko Doi, Kei Muro, et al.
Japanese Journal of Clinical Oncology
|
March 23, 2010
Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for pre-treated metastatic colorectal cancer harboring wild-type KRAS
Kohei Shitara, Tomoya Yokota, Daisuke Takahari, et al.
Clinical Pharmacology and Therapeutics
|
October 7, 2023
Quantitative Analysis of the Concentration of Trifluridine in Tumor Hypoxic Regions Using a Novel Platform Combining Functional Endoscopy and Mass Spectrometry
Shigehiro Koganemaru, Hirobumi Fuchigami, Hiroki Yamashita, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
December 3, 2015
Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
Kohei Shitara, Keisho Chin, Takaki Yoshikawa, et al.
BMC Cancer
|
April 18, 2015
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
Akihito Kawazoe, Kohei Shitara, Shota Fukuoka, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
June 3, 2018
Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer
Akihito Kawazoe, Kohei Shitara, Yasutoshi Kuboki, et al.
Page
of 35
Search research articles
Search
Showing results (151-160 of 344) with videos related to
Sort By:
Page
of 35
BMJ Open
|
July 16, 2020
Protocol for a single-arm confirmatory trial of adjuvant chemoradiation for patients with high-risk rectal submucosal invasive cancer after local resection: Japan Clinical Oncology Group Study JCOG1612 (RESCUE study)
Tomohiro Kadota, Hiroaki Ikematsu, Takeshi Sasaki, et al.
Japanese Journal of Clinical Oncology
|
September 11, 2015
A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study)
Kozo Kataoka, Masanori Tokunaga, Junki Mizusawa, et al.
Japanese Journal of Clinical Oncology
|
April 17, 2018
Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study
Yoichi Naito, Hideaki Takahashi, Kohei Shitara, et al.
BMC Cancer
|
December 29, 2019
Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
Daisuke Kotani, Yasutoshi Kuboki, Satoshi Horasawa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 23, 2016
A multicenter phase II study of TAS-102 monotherapy in patients with pre-treated advanced gastric cancer (EPOC1201)
Hideaki Bando, Toshihiko Doi, Kei Muro, et al.
Japanese Journal of Clinical Oncology
|
March 23, 2010
Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for pre-treated metastatic colorectal cancer harboring wild-type KRAS
Kohei Shitara, Tomoya Yokota, Daisuke Takahari, et al.
Clinical Pharmacology and Therapeutics
|
October 7, 2023
Quantitative Analysis of the Concentration of Trifluridine in Tumor Hypoxic Regions Using a Novel Platform Combining Functional Endoscopy and Mass Spectrometry
Shigehiro Koganemaru, Hirobumi Fuchigami, Hiroki Yamashita, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
December 3, 2015
Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
Kohei Shitara, Keisho Chin, Takaki Yoshikawa, et al.
BMC Cancer
|
April 18, 2015
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
Akihito Kawazoe, Kohei Shitara, Shota Fukuoka, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
June 3, 2018
Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer
Akihito Kawazoe, Kohei Shitara, Yasutoshi Kuboki, et al.
Page
of 35